[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100551623":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":29,"centralContacts":34,"locations":41,"responsibleParty":57,"collaborators":39,"id":59,"slug":39,"hasResults":60,"nctId":61,"briefTitle":62,"officialTitle":63,"acronym":39,"eligibilityCriteria":64,"healthyVolunteers":65,"sex":66,"minAge":67,"maxAge":68,"enrollmentInfo":69,"targetDuration":39,"studyType":72,"phases":73,"briefSummary":75,"conditions":76,"keywords":39,"overallStatus":44,"whyStopped":39,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"Anhui Provincial Hospital","OTHER_GOV",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"[18F]F-PSMA-N5 and [18F]F-PSMA-1007 PET\u002F CT scan","EXPERIMENTAL","Subjects PET\u002FCT imaging: On any two days for two consecutive weeks, each subject underwent a PET\u002F CT scan after intravenous injection of \\[18F\\]F-PSMA-N5 and \\[18F\\]F-PSMA-1007.",[13,14],"Drug: [18F]F-PSMA-N5","Drug: [18F]F-PSMA-1007",[16,23],{"type":17,"name":18,"description":19,"armGroupLabels":20,"otherNames":21},"DRUG","[18F]F-PSMA-N5","Each subject receive a single intravenous injection of \\[18F\\]F-PSMA-N5, and undergo PET\u002FCT imaging within the specificed time.",[9],[22],"[18F]F-PSMA-N5 injection",{"type":17,"name":24,"description":25,"armGroupLabels":26,"otherNames":27},"[18F]F-PSMA-1007","Each subject receive a single intravenous injection of \\[18F\\]F-PSMA-1007, and undergo PET\u002FCT imaging within the specificed time.",[9],[28],"[18F]F-PSMA-1007 injection",[30],{"name":31,"affiliation":32,"role":33},"Qiang Xie","The First Affiliated Hospital of USTC (Anhui Provincial Hospital)","STUDY_CHAIR",[35],{"name":36,"role":37,"phone":38,"phoneExt":39,"email":40},"Qiang Xie, MD","CONTACT","+8613721108043",null,"xieqiang1980@ustc.edu.cn",[42],{"facility":43,"status":44,"city":45,"state":46,"zip":47,"country":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"The First Affiliated Hospital of China University of Science and Technology（Anhui Provincial Hospital）","RECRUITING","Hefei","Anhui","230000","China",{"type":50,"coordinates":51},"Point",[52,53],117.28083,31.86389,{"lat":53,"lon":52},[56],{"name":36,"role":37,"phone":38,"phoneExt":39,"email":40},{"type":58,"investigatorFullName":39,"investigatorTitle":39,"investigatorAffiliation":39,"oldNameTitle":39,"oldOrganization":39},"SPONSOR","100551623",false,"NCT06462495","Head-to-head Comparison of [18F]F-PSMA-N5 With [18F]F-PSMA-1007 PET\u002FCT in PCa Diagnosis, Recurrence, and Metastasis","Head-to-head Comparison of [18F]F-PSMA-N5 With [18F]F-PSMA-1007 PET\u002FCT in Prostate Cancer Diagnosis, Recurrence, and Metastasis: a Prospective Study","Inclusion Criteria:\n\n* Aged from 18 to 90 years old;\n* Complete MRI images and clinical data (such as PSA level, Gleason grade, etc.);\n* Prostate cancer detected by PSA or imaging examination, or clinically suspected recurrence after standardized treatment;\n* simultaneous \\[18F\\]F-PSMA-N5 and \\[18F\\]F-PSMA-1007 examinations within two weeks;\n* Willing to undergo surgery or needle biopsy for pathological examination after examination, or confirmed as prostate cancer by histopathology before or after treatment;\n* Sign informed consent.\n\nExclusion Criteria:\n\n* Patients who cannot cooperate with the examination;\n* Concurrent malignant tumors;\n* Previous alcohol allergy;\n* Patients with liver and kidney dysfunction;\n* Other circumstances deemed by the investigator to be inappropriate for trial participation.",true,"MALE","18 Years","90 Years",{"count":70,"type":71},30,"ESTIMATED","INTERVENTIONAL",[74],"EARLY_PHASE1","To prospectively evaluate the radiodrug biodistribution of a novel PET imaging agent \\[18F\\]F-PSMA-N5 in different organs of prostate cancer patients and its diagnostic efficacy in the diagnosis, recurrence and metastasis of prostate cancer, and to compare with \\[18F\\]F-PSMA-1007.",[77,78],"Prostate Cancer","PET\u002FCT","2024-06-12",{"date":81,"type":82},"2024-06-17","ACTUAL",{"date":84,"type":82},"2024-04-10",{"date":86,"type":71},"2025-12-31",{"name":5,"class":6},1]